September 25, 2017 12:22 PM ET

Pharmaceuticals

Company Overview of Cumberland Pharmaceuticals Inc.

Executive Profile

Caroline R. Young

Independent Director, Cumberland Pharmaceuticals Inc.
AgeTotal Calculated CompensationThis person is connected to 1 Board Member in 1 organization across 2 different industries.

See Board Relationships
43$16,667

Background

Ms. Caroline R. Young serves as the Executive Director of NashvilleHealth. Ms. Young has been an Independent Director of Cumberland Pharmaceuticals Inc. since September 13, 2016. She serves as founding Executive Director of the Tennessee Biotechnology Association. She served as a Director at Nashville Capital Network until July 2015. She served as the President of the Nashville Health Care Council from 2008 to until June 1, 2015. There, she oversaw a series of international ...

Corporate Headquarters

2525 West End Avenue
Nashville, Tennessee 37203

United States

Phone: 615-255-0068
Fax: 615-255-0094

Board Members Memberships

2016-Present
Independent Director

Education

There is no Education data available.

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

Total Annual Cash Compensation$16,667
Total Calculated Compensation$16,667
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
David M. Stack Chairman and Chief Executive Officer
Pacira Pharmaceuticals, Inc.
$1.2M
James E. Brown D.V.M.Co-Founder, Chief Executive Officer, President and Director
DURECT Corporation
$531.3K
Peter M. Hecht Ph.D. Co-Founder, Chief Executive Officer and Director
Ironwood Pharmaceuticals, Inc.
$100.0K
Paul M. Bisaro President, CEO & Director
Impax Laboratories, Inc.
--
Peter S. Greenleaf Chairman & CEO
Sucampo Pharmaceuticals, Inc.
$653.0K
Compensation as of Fiscal Year 2016.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Cumberland Pharmaceuticals Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.